Featured

Novartis announced that the US FDA has approved Kymriah™(tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for...

At the European Society of Medical Oncology (ESMO) 2017 Congress in Madrid, Spain, 8-12 September, AstraZeneca and MedImmune, its global biologics research and development arm,...

If your home floods in the spring, it’s generally an indicator that you have a problem in your house, such as poor drainage or a...

Team of doctors at Fortis Hospital, Shalimar Bagh led by Dr Surender Dabas, Director – Head, Neck and Thoracic Surgical Oncology recently performed two extremely...

Over the last few years, the healthcare industry has undergone an incredible revolution. Mobility solutions deployed across the care continuum are providing higher quality patient...

In recent years, advances in medical technology, knowledge, and new drugs have helped to improve outcomes in cardiovascular disease (CVD) – but nevertheless it remains...

Amgen announced that a new analysis showed lowering low-density lipoprotein cholesterol (LDL-C) levels with Repatha® (evolocumab) reduced the risk of cardiovascular events in a sub-group...